Hmox2-null mice developed insulin resistance, elevated blood pressure, promoted subcutaneous and visceral fat tissue deposition and superoxide production, increased levels of pro-inflammatory cytokines, and decreased serum adiponectin levels (40, 41). Here, ADIPOQ is linked to Insulin resistance.